Muscle relaxation accelerator and therapeutic agent for muscular tissue diseases such as muscle relaxation failure

Details for Australian Patent Application No. 2005238389 (hide)

Owner Aetas Pharma Co., Ltd.

Inventors Kaneko, Noboru

Agent Freehills

Pub. Number AU-B-2005238389

PCT Pub. Number WO2005/105793

Priority 2005-141792 12.04.05 JP; 2004-237533 17.08.04 JP; 2004-134899 28.04.04 JP

Filing date 28 April 2005

Wipo publication date 10 November 2005

Acceptance publication date 6 August 2009

International Classifications

A61P 9/12 (2006.01) Drugs for disorders of the cardiovascular system

A61K 31/554 (2006.01) - having at least one nitrogen and at least one sulfur as ring hetero atoms, e.g. clothiapine, diltiazem

A61P 9/00 (2006.01) Drugs for disorders of the cardiovascular system

A61P 9/04 (2006.01) Drugs for disorders of the cardiovascular system

A61P 9/10 (2006.01) Drugs for disorders of the cardiovascular system

A61P 11/00 (2006.01) Drugs for disorders of the respiratory system

A61P 21/02 (2006.01) Drugs for disorders of the muscular or neuromuscular system

A61P 43/00 (2006.01) Drugs for specific purposes, not provided for in groups

C07D 281/10 (2006.01) Heterocyclic compounds containing rings of more than six members having one nitrogen atom and one sulfur atom as the only ring hetero atoms

C07D 417/06 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group

C07D 417/14 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group

Event Publications

21 December 2006 PCT application entered the National Phase

  PCT publication WO2005/105793 Priority application(s): WO2005/105793

6 August 2009 Application Accepted

  Published as AU-B-2005238389

3 December 2009 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005238390-42- (cycloalkylamino) pyrimidin-4-yl ! - (phenyl) - imidazolin-2one derivatives as p38 MAPkinase inhibitors for the treatment of inflammatory diseases

2005238388-Fused quinoline derivative and use thereof